Page last updated: 2024-12-05

tetracyanoethylene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetracyanoethylene (TCNE) is a powerful electron acceptor and a versatile reagent in organic synthesis. It is a white crystalline solid that is highly soluble in polar solvents. TCNE is synthesized by the reaction of tetracyanoethane with chlorine gas. It is a strong oxidizer and can react with a variety of compounds, including alkenes, alkynes, and aromatics. TCNE is a key component in the preparation of charge-transfer complexes, which have applications in organic electronics and solar cells. It is also used as a starting material for the synthesis of other organic compounds, such as tetracyanoquinodimethane (TCNQ), which is a well-known organic conductor. TCNE is a highly studied compound due to its unique electronic properties and its potential for applications in materials science, organic chemistry, and other fields.'

tetracyanoethene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12635
CHEMBL ID3188794
MeSH IDM0044433

Synonyms (57)

Synonym
c592309ecu ,
unii-c592309ecu
tetrakyanethylen
EN300-19653
ethene, tetracyano-
nsc-24833
tetracyanoethene
ethenetetracarbonitrile
ethylenetetracarbonitrile
tcne
nsc24833
.delta.2,2'-bimalononitrile
tetracyanoethylene ,
delta2,2'-bimalononitrile
ai3-28756
nsc 24833
einecs 211-578-0
ccris 2643
delta(sup 2,2')-bimalononitrile
1,1,2,2-tetracyanoethene
1,1,2,2-tetracyanoethylene
tetrakyanethylen [czech]
ethene-1,1,2,2-tetracarbonitrile
1,1,2,2-ethylenetetracarbonitrile
1,1,2,2-ethenetetracarbonitrile
inchi=1/c6n4/c7-1-5(2-8)6(3-9)4-1
ethylene-1,1,2,2-tetracarbonitrile
670-54-2
GHL.PD_MITSCHER_LEG0.947
tetracyanoethylene, 98%
T0077
AKOS000119978
A835618
eth-1-ene-1,1,2,2-tetracarbonitrile
dtxcid6029385
NCGC00260486-01
cas-670-54-2
dtxsid7049425 ,
tox21_202940
STL371968
tetracyanoethylene [mi]
BBL027360
J-200117
STR01337
(nc)2cc(cn)2
ethylene tetra carbonitrile
1,1,2,2-ethylenetetracarbonitrile #
ethylene, tetracyano-
CHEMBL3188794
T3264
mfcd00001850
2,3-dicyano-but-2-enedinitrile
percyanoethylene
Q413864
ethene tetracarbonitrile
tetracyanoethylene (purified by sublimation)
D87657

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Colchicine in pure form and in dosage form was applied in this study."( Spectroscopic studies of charge transfer complexes between colchicine and some pi acceptors.
Arslan, M; Duymus, H, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency15.81250.000714.592883.7951AID1259369; AID1259392
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency32.22630.001022.650876.6163AID1224838; AID1224839
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency1.80030.001530.607315,848.9004AID1224841
thyroid stimulating hormone receptorHomo sapiens (human)Potency14.30010.001628.015177.1139AID1259385
histone deacetylase 9 isoform 3Homo sapiens (human)Potency32.01380.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency11.91980.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (5.56)18.7374
1990's4 (5.56)18.2507
2000's30 (41.67)29.6817
2010's31 (43.06)24.3611
2020's3 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 64.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index64.59 (24.57)
Research Supply Index4.30 (2.92)
Research Growth Index5.19 (4.65)
Search Engine Demand Index103.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (64.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.74%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other71 (97.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]